Indian Journal of Medical Microbiology IAMM  | About us |  Subscription |  e-Alerts  | Feedback |  Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Ahead of Print | Current Issue | Archives | Search | Instructions  
Users Online: 1111 Official Publication of Indian Association of Medical Microbiologists 
  Search
 
  
 ~  Similar in PUBMED
 ~  Search Pubmed for
 ~  Search in Google Scholar for
 ~Related articles
 ~  Article in PDF (325 KB)
 ~  Citation Manager
 ~  Access Statistics
 ~  Reader Comments
 ~  Email Alert *
 ~  Add to My List *
* Registration required (free)  

 
 ~  Abstract
 ~ Introduction
 ~  Materials and Me...
 ~ Results
 ~ Discussion
 ~ Conclusion
 ~  References
 ~  Article Tables

 Article Access Statistics
    Viewed123    
    Printed4    
    Emailed0    
    PDF Downloaded9    
    Comments [Add]    

Recommend this journal

 


 
  Table of Contents  
BRIEF COMMUNICATION
Year : 2017  |  Volume : 35  |  Issue : 1  |  Page : 124-128
 

Antimicrobial susceptibility of Leptospira spp. isolated from environmental, human and animal sources in Malaysia


1 Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia
2 Faculty of Veterinary Medicine, Universiti Putra Malaysia, Selangor, Malaysia

Date of Web Publication16-Mar-2017

Correspondence Address:
Kwai Lin Thong
Faculty of Science, Institute of Biological Sciences, University of Malaya, 50603 Kuala Lumpur
Malaysia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmm.IJMM_15_458

Rights and Permissions

 ~ Abstract 


Leptospirosis is a zoonosis with worldwide distribution caused by pathogenic spirochetes of the genus Leptospira. The aim of this study was to evaluate the susceptibility of isolates obtained from different hosts. A total of 65 Leptospira isolates from humans (n = 1), zoonoses (rat, n = 60; dog, n = 1; swine, n = 1) and environment (n = 2) were tested against six antibiotics. All the isolates were resistant to trimethoprim and sulphamethoxazole and had high MIC toward chloramphenicol (MIC90: 6.25 μg/ml). All except one environment isolate were sensitive to ampicillin, doxycycline and penicillin G.


Keywords: Antimicrobial susceptibility, Leptospira, leptospirosis, minimal inhibitory concentration


How to cite this article:
Benacer D, Zain SN, Ooi PT, Thong KL. Antimicrobial susceptibility of Leptospira spp. isolated from environmental, human and animal sources in Malaysia. Indian J Med Microbiol 2017;35:124-8

How to cite this URL:
Benacer D, Zain SN, Ooi PT, Thong KL. Antimicrobial susceptibility of Leptospira spp. isolated from environmental, human and animal sources in Malaysia. Indian J Med Microbiol [serial online] 2017 [cited 2017 Mar 26];35:124-8. Available from: http://www.ijmm.org/text.asp?2017/35/1/124/202325





 ~ Introduction Top


Leptospirosis is an emerging zoonotic disease with worldwide distribution.[1] It is caused by pathogenic spirochetes of the genus Leptospira. Approximately, one-half of the pathogenic serovars belong to Leptospira interrogans or Leptospira borgpetersenii.[2] Rodents are the principal known maintenance hosts, besides domestic animals, livestock and wild animals.[2] Humans become accidental hosts by acquiring the infection through direct contact with urine, blood or infected animal tissue or indirect contact with water or soil contaminated with the urine from reservoir animals.[1] Clinically, symptoms of infection may range in severity from mild to fatal, depending on the infection stage. However, the clinical presentation of leptospirosis is unspecific, which frequently leads to misdiagnosis.[3] In Malaysia, misdiagnosis of this infection has become a critical issue, where dengue, malaria and other infectious diseases with overlapping clinical presentations are endemic. Treatment normally follows an empirical chemotherapy route, which requires information regarding the susceptibilities of Leptospira isolates to various antimicrobial agents. Effective and appropriate antibiotic selection for treatment is essential to prevent complications. Several studies have been carried out on Leptospira isolates' susceptibilities. However, these studies have a number of limitations, such as using laboratory-passaged strains or a small number of Leptospira strains.[4] Due to the endemicity of leptospirosis in Malaysia [5] as well as the dramatic increase in reported cases over the last decade, there is a critical need to determine the effectiveness of common antibiotics in controlling this organism. However, no information is available on the antimicrobial susceptibilities of Malaysian Leptospira isolates. Therefore, the aim of this study is to monitor and evaluate the susceptibility of recent local isolates obtained from different hosts and sites to traditional antimicrobial compounds used for leptospirosis treatment.


 ~ Materials and Methods Top


Bacterial strains

Sixty-five Leptospira isolates representing four different species and at least five serovars were included in the testing. These isolates from environmental (water, n = 2) and animal sources (rat, n = 60; dog, n = 1; swine, n = 1) were isolated between 2011 and 2014 from different sites in six states in Peninsular Malaysia.[2],[5] One clinical isolate was provided by the Royal Tropical Institute (KIT), Amsterdam, Netherlands. The strain was originally isolated from a human in Malaysia by Alexander et al.[6] The isolates were maintained in culture in Ellinghausen-McCullough-Johnson-Harris (EMJH) medium. Information on the isolates is summarised in [Table 1].
Table 1: Strains of Leptospira tested and their susceptibility to six antimicrobial agents

Click here to view


Antimicrobial agents

The antimicrobial solutions employed in this study were prepared from reagent grade powders to produce 1 mg/ml solutions using solvents and diluents suggested in the Clinical and Laboratory Standards Institute document M100-S22[7] or according to the manufacturer's suggestions if available. Six antimicrobial agents, including doxycycline, penicillin G, trimethoprim, ampicillin, chloramphenicol (MP Biomedicals, France) and sulphamethaxazole (Sigma-Aldrich; St. Louis, MO, USA) were used to test the Leptospira isolates' antimicrobial susceptibility. The stock antimicrobial solutions were stored at −80°C in divided one-time use aliquots.

Susceptibility testing

Broth microdilution testing was performed as reported by Murray and Hospenthal [4] and Chakraborty et al.[8] The antibiotic concentrations ranged from 25.0 to 0.01 µg/ml (units/ml for penicillin), with the exception of sulphamethaxazole and trimethoprim, which were tested at 3200 to 12.5 µg/ml. The strain L. interrogans serovar Icterohaemorrhagiae was used for internal validation with minimal inhibitory concentration (MIC) parameters and served as the control strain.[4] All tests were performed in triplicate and included positive (bacteria only) and negative controls (medium only). The Leptospira inoculum used for testing was prepared from 7-day-old cultures grown in liquid EMJH medium at 30°C. Then, 100 µl Leptospira inoculum of 2 × 106 leptospiral organisms/ml was added, and the 96 well plates were incubated at 30°C, with each well having a final volume of 200 µl. Following 3 days of incubation, 20 µl of 10X alamarBlue (Invitrogen, Cleveland, OH, USA) was added to each well. AlamarBlue is an oxidation-reduction indicator that changes colour from dark blue to bright pink in response to the chemical reduction of the growth medium resulting from cell development. The colour of each well was documented on the 5th day of incubation, and the MICs were recorded as the concentration in the well containing the lowest concentration without blue-to-pink colour change.


 ~ Results Top


The MIC90 values are reported in [Table 1]. All isolates were resistant to trimethoprim and sulphamethoxazole (MIC90: 1600 µg/ml). All isolates had an MIC90 range of 3.13–6.25 µg/ml to chloramphenicol, except that from swine (LS01/11) and one isolate from rat (LR31/13) which showed higher MICs of 12.5 and 25 µg/ml, respectively. Overall, penicillin G and ampicillin appeared to be effective for all clinical and zoonotic isolates with MIC90 between 0.1 and 0.2 µg/ml. Only the dog isolate showed a slightly higher MIC toward penicillin G (0.39 µg/ml) compare to the rest while the lowest was toward the swine isolate (<0.01 µg/ml). However, the environmental isolate L. kirschneri (LE02/11) was resistant to penicillin G and ampicillin as the MIC reported was 25 µg/ml. The MICs of doxycycline ranged from 0.2 to 0.78 µg/ml, but one zoonotic (LS01/11) and 2 environmental isolates (LE01/11, LE02/11) displayed a higher MIC toward doxycycline (3.13 µg/ml) compared to the other isolates although still remained susceptible. Overall, doxycycline was more effective on all isolates tested compared to ampicillin and penicillin G.


 ~ Discussion Top


Leptospirosis is an endemic disease in Malaysia, occurring in both urban and rural locations. The local absence of sensitive, specific and rapid methods of diagnosing leptospirosis makes it difficult to distinguish it from other febrile illnesses. The misdiagnosis of leptospirosis often leads to treatment with a broad range of antimicrobials that cover the febrile syndromes of various local illnesses. Therefore, this study was carried out to monitor and determine the susceptibility patterns in the different isolates of leptospirosis reflecting on their effectiveness in the treatment of leptospirosis.

In our study, both trimethoprim and sulphamethoxazole were found ineffective against all isolates tested. This finding is in agreement with previous studies.[8],[9] Trimethoprim and sulphamethoxazole have sometimes been applied in combination for their synergistic action in providing a broad-spectrum bactericidal antimicrobial coverage before definitive diagnosis.[10] However, the resistance of Leptospira strains to these antibiotics may compel health workers to consider other antileptospiral drugs in cases where the diagnosis of leptospirosis is inconclusive.

The local isolates demonstrated a higher MIC toward chloramphenicol, which is in agreement with the findings of Murray and Hospenthal.[4] Previously, chloramphenicol appeared to be effective against Leptospira in experimental mice.[11] However, a higher concentration was required to produce an inhibition or a bactericidal effect on Leptospira strains.[4] Unlike chloramphenicol, ampicillin displayed a lower MIC to the isolates tested, except for one environmental isolate that was resistant (MIC: 25 µg/ml). Administration of ampicillin was a potential option in the treatment of this illness both in vivo and in vitro.[8],[12],[13] However, the action of ampicillin against leptospirosis is restricted and cannot be distributed to all organ tissues, such as the kidneys and the heart, rendering it ineffective in clearing leptospires located in protected sites.[13] Currently, penicillin G and doxycycline are recognised as ideal drugs for the treatment of leptospirosis.[9] The MIC results of penicillin G were similar to those produced by ampicillin. However, penicillin G is generally recommended for treating severe leptospirosis. The advantages of using penicillin G include low toxicity and the potential to administer the drug intramuscularly or intravenously at high doses in the early stages of infection.[14] The efficacy of penicillin was compared with ceftriaxone in a trial study in treatment of severe leptospirosis, where one group (n = 86) was given intravenous penicillin G 1.5 million unit/6 h and second group (n = 87) was given intravenous ceftriaxone 1 g daily for 7 days. After 7 days follow-up, no significant difference was observed for median duration of fever, mortality and complications such as renal failure, jaundice and thrombocytopenia.[15]

In this study, one environmental and one zoonotic isolate showed a slightly higher MIC with doxycycline than the rest of the isolates. However, this antibiotic was still effective on all isolates – a finding which correlated with previous studies.[8],[16] Doxycycline has been widely recommended and utilised for the prophylaxis and treatment of mild leptospirosis.[17] In the leptospirosis outbreak that occurred in an eco-challenge multisport competition in Sabah, Malaysia, athletes who had taken doxycycline before the challenge were spared from infection.[18] Truccolo et al.[13] used quantitative PCR assay to evaluate ampicillin, ofloxacin and doxycycline for treatment of experimental leptospirosis. The results showed the ability of ampicillin at a high dose (100 mg/kg of body weight) to clear leptospires from the host, except from kidneys and heart, where 102 leptospires/g remained at day 6. Ofloxacin (30 mg/kg) was unable to clear bacteria from blood or kidneys. With doxycycline (10 mg/kg), the clearance of leptospires occurred in 2 days in all the target organs studied, with the exception of liver, which required 3 days. They concluded that doxycycline had the potential for the treatment of leptospirosis cases compared to other two antibiotics used.

The environmental isolate L. kirschneri had higher MIC with the antibiotics tested compared to clinical and zoonotic isolates. In a study performed by Murray and Hospenthal,[7] the results indicated that L. kirschneri had a higher MIC toward some of the antibiotics tested compared to other species.


 ~ Conclusion Top


Doxycycline, ampicillin and penicillin G are still effective against all clinical and zoonotic isolates. However, further testing on larger numbers of environmental isolates is required to determine the most suitable antibiotic treatment for leptospirosis.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
 ~ References Top

1.
Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: A zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-71.  Back to cited text no. 1
    
2.
Benacer D, Mohd Zain SN, Amran F, Galloway RL, Thong KL. Isolation and molecular characterization of Leptospira interrogans and Leptospira borgpetersenii isolates from the urban rat populations of Kuala Lumpur, Malaysia. Am J Trop Med Hyg 2013;88:704-9.  Back to cited text no. 2
    
3.
Bruce MG, Sanders EJ, Leake JA, Zaidel O, Bragg SL, Aye T, et al. Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Trop 2005;96:36-46.  Back to cited text no. 3
    
4.
Murray CK, Hospenthal DR. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob Agents Chemother 2004;48:1548-52.  Back to cited text no. 4
    
5.
Benacer D, Woh PY, Mohd Zain SN, Amran F, Thong KL. Pathogenic and saprophytic Leptospira species in water and soils from selected urban sites in peninsular Malaysia. Microbes Environ 2013;28:135-40.  Back to cited text no. 5
    
6.
Alexander AD, Evans LB, Toussaint AJ, Marchwicki RH, Mccrumb FR Jr. Leptospirosis in Malaya. II. Antigenic analysis of 110 Leptospiral strains and other serologic studies. Am J Trop Med Hyg 1957;6:871-89.  Back to cited text no. 6
    
7.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 22nd Informational Supplement. CLSI Document M100-S22. Wayne, Pennsylvania, USA: Clinical and Laboratory Standards Institute; 2012.  Back to cited text no. 7
    
8.
Chakraborty A, Miyahara S, Villanueva SY, Gloriani NG, Yoshida S.In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrob Agents Chemother 2010;54:5403-5.  Back to cited text no. 8
    
9.
Miraglia F, Matsuo M, Morais ZM, Dellagostin OA, Seixas FK, Freitas JC, et al. Molecular characterization, serotyping, and antibiotic susceptibility profile of Leptospira interrogans serovar Copenhageni isolates from Brazil. Diagn Microbiol Infect Dis 2013;77:195-9.  Back to cited text no. 9
    
10.
Chetchotisakd P, Chierakul W, Chaowagul W, Anunnatsiri S, Phimda K, Mootsikapun P, et al. Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiority, randomised controlled trial. Lancet 2014;383:807-14.  Back to cited text no. 10
    
11.
Dunn MC, Thompson PE. Chemotherapy of experimental leptospirosis with chloramphenicol, (chloromycetin), subtilin and penicillin G. J Infect Dis 1953;92:33-9.  Back to cited text no. 11
    
12.
Alt DP, Bolin CA. Preliminary evaluation of antimicrobial agents for treatment of Leptospira interrogans serovar pomona infection in hamsters and swine. Am J Vet Res 1996;57:59-62.  Back to cited text no. 12
    
13.
Truccolo J, Charavay F, Merien F, Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 2002;46:848-53.  Back to cited text no. 13
    
14.
Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433-5.  Back to cited text no. 14
    
15.
Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003;36:1507-13.  Back to cited text no. 15
    
16.
Ressner RA, Griffith ME, Beckius ML, Pimentel G, Miller RS, Mende K, et al. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. Antimicrob Agents Chemother 2008;52:2750-4.  Back to cited text no. 16
    
17.
Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004;39:1417-24.  Back to cited text no. 17
    
18.
Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S, et al. Leptospirosis in “Eco-Challenge” athletes, Malaysian Borneo, 2000. Emerg Infect Dis 2003;9:702-7.  Back to cited text no. 18
    



 
 
    Tables

  [Table 1]



 

Top
Print this article  Email this article
 

    

2004 - Indian Journal of Medical Microbiology
Published by Wolters Kluwer - Medknow

Online since April 2001, new site since 1st August '04